Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 3
2023 4
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review.
De Vitis LA, Schivardi G, Caruso G, Fumagalli C, Vacirca D, Achilarre MT, Aloisi A, Garbi A, Zanagnolo V, Aletti G, Guerini-Rocco E, Mariani A, Maggioni A, Barberis M, Bogani G, Colombo N, Multinu F, Betella I. De Vitis LA, et al. Among authors: schivardi g. Int J Gynecol Cancer. 2024 Feb 5;34(2):229-238. doi: 10.1136/ijgc-2023-004864. Int J Gynecol Cancer. 2024. PMID: 38135437
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes.
Cuccu I, Raspagliesi F, Malzoni M, Vizza E, Papadia A, Di Donato V, Giannini A, De Iaco P, Perrone AM, Plotti F, Angioli R, Casarin J, Ghezzi F, Cianci S, Vizzielli G, Restaino S, Petrillo M, Sorbi F, Multinu F, Schivardi G, De Vitis LA, Falcone F, Lalli L, Berretta R, Mueller MD, Tozzi R, Chiantera V, Benedetti Panici P, Fanfani F, Scambia G, Bogani G. Cuccu I, et al. Among authors: schivardi g. Eur J Surg Oncol. 2024 Apr;50(4):108018. doi: 10.1016/j.ejso.2024.108018. Epub 2024 Feb 15. Eur J Surg Oncol. 2024. PMID: 38428106
Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
De Vitis LA, Fumagalli D, Schivardi G, Capasso I, Grcevich L, Multinu F, Cucinella G, Occhiali T, Betella I, Guillot BE, Pappalettera G, Shahi M, Fought AJ, McGree M, Reynolds E, Colombo N, Zanagnolo V, Aletti G, Langstraat C, Mariani A, Glaser G. De Vitis LA, et al. Among authors: schivardi g. Int J Gynecol Cancer. 2024 May 6;34(5):689-696. doi: 10.1136/ijgc-2023-005173. Int J Gynecol Cancer. 2024. PMID: 38514100
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study.
Cucinella G, Schivardi G, Zhou XC, AlHilli M, Wallace S, Wohlmuth C, Baiocchi G, Tokgozoglu N, Raspagliesi F, Buda A, Zanagnolo V, Zapardiel I, Jagasia N, Giuntoli R, Glickman A, Peiretti M, Lanner M, Chacon E, Di Guilmi J, Pereira A, Laas-Faron E, Fishman A, Nitschmann CC, Kurnit K, Moriarty K, Joehlin-Price A, Lees B, Covens A, De Brot L, Taskiran C, Bogani G, Landoni F, Grassi T, Paniga C, Multinu F, De Vitis LA, Hernández A, Mastroyannis S, Ghoniem K, Chiantera V, Shahi M, Fought AJ, McGree M, Mariani A, Glaser G. Cucinella G, et al. Among authors: schivardi g. Int J Gynecol Cancer. 2024 Feb 5;34(2):179-187. doi: 10.1136/ijgc-2023-005032. Int J Gynecol Cancer. 2024. PMID: 38088182
Epigenomics may begin to explain in vitro differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer.
El Khoury LY, Lin WH, Smadbeck JB, Barrett MT, Sadeghian D, McCune AF, Karagouga G, Cheville JC, Harris FR, Kinsella LM, Feathers RW, Schafer Klein JL, Walther-Antonio MR, Johnson SH, Penheiter AR, Cucinella G, Schivardi G, Bhagwate A, Borad MJ, Mansfield AS, Murphy SJ, Mariani A, Vasmatzis G, Anastasiadis PZ, Weroha SJ, Larish AM. El Khoury LY, et al. Among authors: schivardi g. Epigenomics. 2023 Mar;15(5):283-292. doi: 10.2217/epi-2023-0026. Epub 2023 May 22. Epigenomics. 2023. PMID: 37212177
Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study.
Schivardi G, Caruso G, De Vitis LA, Cucinella G, Multinu F, Zanagnolo V, Baiocchi G, De Brot L, Occhiali T, Vizzielli G, Giuntoli R, Fought AJ, McGree ME, Shahi M, Mariani A, Glaser GE. Schivardi G, et al. Int J Gynecol Cancer. 2024 Oct 7;34(10):1561-1569. doi: 10.1136/ijgc-2024-005672. Int J Gynecol Cancer. 2024. PMID: 39153830
A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer.
Betella I, Fumagalli C, Rafaniello Raviele P, Schivardi G, De Vitis LA, Achilarre MT, Aloisi A, Garbi A, Maruccio M, Zanagnolo V, Aletti G, Guerini-Rocco E, Mariani A, Maggioni A, Barberis M, Colombo N, Multinu F. Betella I, et al. Among authors: schivardi g. Int J Gynecol Cancer. 2022 Jun 22:ijgc-2022-003480. doi: 10.1136/ijgc-2022-003480. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35732351
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
Valenza C, Spada F, Multinu F, Benini L, Borghesani M, Algeri L, Rubino M, Pisa E, Gervaso L, Cella CA, Carinelli S, Bruni S, Schivardi G, Curigliano G, Zanagnolo V, Aletti G, Colombo N, Fazio N. Valenza C, et al. Among authors: schivardi g. Endocr Relat Cancer. 2023 Aug 14;30(10):e230112. doi: 10.1530/ERC-23-0112. Print 2023 Oct 1. Endocr Relat Cancer. 2023. PMID: 37428640
19 results